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Abstract
Background: The highly plastic nature of adrenal cortex suggests the presence of 
adrenocortical stem cells (ACSC), but the exact in vivo identity of ACSC remains elusive. 
A few studies have demonstrated the differentiation of adipose or bone marrow-derived 
mesenchymal stem cells (MSC) into steroid-producing cells. We therefore investigated 
the isolation of multipotent MSC from human adrenal cortex.
Methods: Human adrenals were obtained as discarded surgical material. Single-cell 
suspensions from human adrenal cortex (n = 3) were cultured onto either complete 
growth medium (CM) or MSC growth promotion medium (MGPM) in hypoxic condition. 
Following ex vivo expansion, their multilineage differentiation capacity was evaluated. 
Phenotype markers were analysed by immunocytochemistry and flow cytometry for 
cell-surface antigens associated with bone marrow MSCs and adrenocortical-specific 
phenotype. Expression of mRNAs for pluripotency markers was assessed by q-PCR.
Results: The formation of colony-forming unit fibroblasts comprising adherent cells with 
fibroblast-like morphology were observed from the monolayer cell culture, in both CM 
and MGPM. Cells derived from MGPM revealed differentiation towards osteogenic and 
adipogenic cell lineages. These cells expressed cell-surface MSC markers (CD44, CD90, 
CD105 and CD166) but did not express the haematopoietic, lymphocytic or HLA-DR 
markers. Flow cytometry demonstrated significantly higher expression of GLI1 in cell 
population harvested from MGPM, which were highly proliferative. They also exhibited 
increased expression of the pluripotency markers.
Conclusion: Our study demonstrates that human adrenal cortex harbours a 
mesenchymal stem cell-like population. Understanding the cell biology of adrenal 
cortex- derived MSCs will inform regenerative medicine approaches in autoimmune 
Addison’s disease.
Introduction
The plasticity of adrenal cortex has been shown to confer 
a therapeutic potential for immunomodulatory and 
regenerative therapy in adrenal insufficiency (1, 2, 3). 
However, despite the demonstration of the regenerative 
capacity of rodent adrenal capsule nearly 80  years ago 
(4), the exact in vivo identity of adrenocortical stem cells 
(ACSCs) remains elusive. Adult mesenchymal stromal 
or stem cells (MSCs) have drawn significant interest 
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among researchers in the stem cell field, owing to their 
multipotent differentiation capacity, low tumorigenicity 
and tolerogenic nature for allogenic cell-based therapies. 
They were initially isolated from the adult bone marrow 
and have subsequently been harvested from several 
other tissues, including the adipose tissue (5), pancreas 
(6), umbilical cord (7), synovium (8), dental pulp (9), 
trabeculae bone (10), peripheral blood (11) and skeletal 
muscle (12, 13).
MSCs lack a unique and specific surface antigen that 
can be used for positive selection. Hence, the characteristics 
of bone marrow–derived MSCs are commonly used as 
the ‘gold standard’ to define MSCs derived from other 
tissues. Bone marrow–derived MSCs exhibit the ability to 
adhere to plastic dishes in a standard culture condition 
and express a set of phenotypic markers on their surface, 
including CD44, CD90, CD105 and CD166 (14, 15). 
They appear first as adherent, single colony clusters 
(colony-forming unit fibroblasts CFU-F) before growing 
as a homogenous population of adherent cells on culture 
dishes (16). They also have the capacity to differentiate 
along mesodermal lineages into osteocytes, chondrocytes 
and adipocytes (14, 15), following specific in vitro culture 
condition and supplementation with exogenous soluble 
factors (17).
Although the exact in vivo identity of ACSCs is yet to 
be defined in either rodents or humans, they are thought 
to reside in the capsular and subcapsular regions of the 
adrenal cortex. A few important transcription factors 
and signalling pathways (e.g. steroidogenic factor 1 
(SF1), sonic hedgehog signalling pathway (SHH-GLI)) 
have been identified as being crucial in the maintenance 
and regulation of ACSCs (18). Conceptually, MSCs are 
the postnatal progenitor cells of most derivatives of 
mesoderm (13) and the adrenal gland originates from 
the intermediate mesoderm embryonically. Therefore, 
adrenocortical progenitor cells are likely derived from 
MSC or a closely allied cell-type. In recent years, a few 
studies have demonstrated that adenovirus-mediated 
forced expression of SF1 could transform rodent and 
human adipose tissue or bone marrow-derived MSCs into 
steroidogenic cells, with the ability to produce multiple 
steroid hormones in response to adrenocorticotropic 
hormone (19, 20, 21, 22, 23). This finding suggests 
that MSCs represent a potential source of stem cells for 
producing steroidogenic cells. Hence, we investigated the 
direct isolation and characterisation of MSCs from human 
adrenal cortex, which could potentially be the previously 
uncharacterised ACSC.
Materials and methods
Primary cell culture of human adrenal cortical cells
Adult adrenal tissue was obtained with written consent 
from patients undergoing radical nephrectomy for upper 
pole renal cell carcinoma, where the planned surgery 
meant that the adrenal gland would have to be sacrificed. 
The study was approved by the National Research Ethics 
Service Committee North East-Sunderland Research Ethics 
Committee (12/NE/0101). The adrenal cortical tissue was 
separated from fat and the adrenal medulla by removing 
tissue adjacent to the central vein. Adrenal cortex with intact 
capsule was then minced and enzymatically dispersed for 
30 min in a digestive solution comprising 0.2% collagenase 
(2 mg/mL) (Sigma) and 0.01% deoxyribonuclease I (DNAse 
I) (0.1 mg/mL) (Sigma), at 37°C. The digested tissues were 
then disaggregated and filtered through a 70 µm nylon cell 
strainer. The undigested tissue fragments were resubmitted 
to the same digestion procedure until all tissues were 
fully digested. The filtered cells were centrifuged and 
re-suspended in two types of growth media. Half of the 
adrenocortical cells were seeded in a complete growth 
medium (CM), comprising DMEM: Ham F12 medium 
with 1% (v/v) penicillin/streptomycin, 10% fetal bovine 
serum (FBS; v/v), 0.25% ascorbic acid (Sigma) and 0.5% 
insulin-transferrin-selenium (ITS; Thermo Fisher), at a 
density of 1.0 × 106 per T-75 cell culture flask at 37°C, under 
an atmospheric oxygen tension of 20% and 5% CO2. The 
remaining half of the cell suspension was seeded in a 
MSC growth promotion medium (MGPM; alpha modified 
Eagle’s medium (aMEM), 10% (vol/vol) FBS, 5 ng/mL FGF2 
(Sigma)), at a cell density of 1 × 106 cells/T-75 flask and 
cultured at 37°C with low oxygen tension of 5% O2 with 
5% CO2. Non-adherent cells were removed after 48 h and 
the medium was changed every 3 days. Colony-forming 
unit fibroblasts (CFU-Fs) were counted in each culture 
every 2–3 days. Established cultures of adrenal cells seeded 
in either a complete medium or MGPM were sub-cultured 
when 80–90% confluent by enzymatic detachment 
using TrpLE Express (Invitrogen) and seeded at a density 
of 1 × 106/75 cm2 density. All cell culture reagents were 
purchased from Gibco (Invitrogen) unless otherwise stated.
Immunocytochemistry/immunofluorescent 
staining study
Following first passage of the primary cell culture, cells 
were re-plated onto sterile coverslips and cultured for 
a further 24–48 h. Monolayer cells were washed with 
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1% phosphate buffered saline (PBS) and fixed in 2% 
paraformaldehyde for 10 min at room temperature. 
Autofluorescence was quenched with 1 M ammonia 
chloride for 5 min. Antigen retrieval was carried out where 
appropriate by incubating the cells in 0.1% Triton X-100 
for 3 min at room temperature followed by 3 washes with 
PBS. Antigenic blocking was performed with 1% bovine 
serum albumin (BSA) and 5% goat serum for 30 min at 
room temperature. This was followed by incubation 
with the primary antibodies in a humidified chamber 
overnight at 4°C. Cells were then washed with PBS and 
incubated with appropriate secondary antibodies at room 
temperature for 1 h in the darkness. Cells were then 
washed and mounted with Vectashield containing 4ʹ,6-
diamidino-2-phenyl-indole (DAPI) (Vector Laboratories, 
Peterborough, UK). The cells were visualised immediately 
using an AxioImager Z1 microscope (Zeiss fluorescent 
microscope with ApoTome attachment). A negative 
control, without primary antibodies, was used to 
identify background autofluorescence and also to check 
for nonspecific binding. The isotype-matched species 
antibodies (Santa Cruz Biotechnology) were also used 
as IgG isotype controls to check for isotype-related 
background staining. The dilution and manufacturer 
of the primary and secondary antibodies are detailed in 
Supplementary Table  1 (see section on supplementary 
data given at the end of this article).
Fluorescence-activated cell sorting (FACS)
Flow cytometry was used to characterise the 
immunophenotypic profile of primary human 
adrenocortical cells. A set of positive and negative cell-
surface markers were used to define MSCs, as described 
by the position paper of the International Society for 
Cellular Therapy (ISCT) (15). The haematopoetic MSCs 
isolated from a post-trauma knee joint aspirate were used 
as a positive control (24). Following the first and second 
passage for cells cultured in CM and MGPM respectively, 
adherent cells were detached and re-suspended in a 
fluorescence-activated cell sorting (FACS) buffer (PBS with 
0.1% (vol/vol) BSA) at a concentration of 5 × 106 cells/mL. 
These cells were filtered through a 100 µm nylon cell 
strainer and transferred to sterile microfuge tubes 
(1 × 106 cells/200 µL/tube). For indirect staining, the 
single-cell suspensions were incubated at 4°C for 1 h 
with appropriate unconjugated primary antibodies or 
isotype-match control antibodies. Cells were washed and 
incubated with appropriate secondary antibodies at 4°C 
in the darkness for 40 min. They were then washed twice 
with cold PBS and re-suspended in a 500 µL FACS buffer 
for immediate analysis. For direct flow cytometry, single-
cell suspensions were incubated with fluorochrome-
conjugated primary antibodies on ice and in the dark 
for 40 min. They were washed twice with cold PBS and 
re-suspended in 500 µL of FACS buffer for immediate 
analysis. For intracellular staining with anti-GLI1 and 
DAX1 antibodies, 100 µL of a fixation medium from 
the Fix and Perm cell permeabilisation kit (Invitrogen) 
were added to 100 µL of single-cell suspension following 
detachment of monolayer cells. These cells were incubated 
at room temperature for 15 min and washed once with 
1 mL of PBS. 100 µL of permeabilisation medium and the 
appropriate unconjugated antibody or the corresponding 
isotype control were added. Cells were incubated for 
20 min at room temperature and washed once with 1 mL of 
PBS. The cell suspensions were incubated with secondary 
antibodies on ice and in the darkness for 40 min. Cells 
were then washed twice and re-suspended in a FACS 
buffer for immediate analysis.
The controls comprised unstained cells, cells 
incubated with secondary antibodies only and isotype-
matched species antibodies as IgG control. The dilution 
and manufacture of the antibodies and fluorochromes 
used are detailed in Supplementary Table 2. Data analysis 
was performed using BD FACSDiva software, version 8 
(BD, Oxford, UK) and Venturi One, version 2 software.
In vitro MSC multilineage differentiation capacity
Adrenal cortex-derived cells cultured in MGPM and CM 
were assessed for osteogenic, adipogenic and chondrogenic 
differentiation capacity following the second passage. 
All images of the stained monolayer cells were acquired 
using the Nikon Digital Sight–DSFi1 camera and Nikon 
NIS-Elements D software (Nikon Metrology, UK).
Osteogenic differentiation
Cells were seeded at 2.5 × 104 cells/mL/well in a 12-well 
plate in a 1:1 DMEM:Ham F12 medium enriched with 
10% FBS. Cells were allowed to attach overnight and 
the medium was replaced with StemPro osteogenesis 
differentiation medium (Invitrogen) the next day. The 
medium was changed every 3  days and the cells were 
maintained in an osteogenesis differentiation medium for 
21 days. The cell monolayer was then fixed in 2% (v/v) 
paraformaldehyde prior to staining with Alizarin Red 
S (ARS), for detection of calcium-rich deposits. In each 
well of a 12-well plate, cells were incubated with 1 mL 
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of 1% Alizarin Red S solution (v/v) at room temperature 
for 30 min. Cells were then washed, air-dried and images 
acquired.
Adipogenic differentiation
Following plating on a 12-well plate at a density of 
10 × 104 cells/mL/well in a DMEM:Ham F12 medium 
enriched with 10% (vol /vol) FBS, cells were incubated 
overnight and induced with StemPro adipogenesis 
differentiation medium (Invitrogen) the next day. 
The medium was renewed every 3  days and cells were 
maintained in the adipogenic medium for 21 days. The 
cell monolayer was fixed in 2% (v/v) paraformaldehyde 
at room temperature for 10 min, before staining with Oil 
Red O for triglyceride or lipid vacuoles. Paraformaldehyde 
was removed and the monolayers were washed twice 
with ddH2O. The cells were then washed with 60% 
(vol/vol) isopropanol for 5 min at room temperature, 
followed by incubation with 1 mL of Oil Red O (Sigma 
Aldrich) solution for triglyceride or lipid vacuoles at room 
temperature for 15 min. The cell monolayer was washed 4 
times and images acquired.
Chondrogenic differentiation
A pellet culture system was used to assess chondrogenic 
differentiation ability. Following second passage, 2 × 106 
adrenocortical cells were re-suspended in 4 mL of StemPro 
chondrogenic differentiation medium (Invitrogen) to a 
final cell density of 5 × 105 cells/pellet. 1 mL aliquots were 
transferred to sterile 15 mL polypropylene conical tubes 
and centrifuged to the bottom. The tubes were loosely 
capped to allow for gas exchange. The cell pellets were 
incubated in a low oxygen tension of 5% O2, hypoxic 
incubator. The chondrogenic medium was changed 
once every 3  days. Safranin O staining was carried out 
to characterise the formation of glycosaminoglycans 
within the cell pellet following 21 days of chondrogenic 
induction. The cell pellet was embedded in paraffin and 
processed via a machine processor. Cell pellet sections 
embedded in wax were then deparaffinised through 
Histoclear (4 × 10 min), rehydrated through 100% ethanol 
and deionised water. The sections were then stained in 
Harris’ haematoxylin for 4 min, de-stained in acid-alcohol 
for 10 s and rinsed in deionised water. This was followed 
by staining with 0.02% aqueous fast green (FCF) (Sigma 
Aldrich) for 3 min, rinsing in 1% acetic acid for 30 s, then 
staining with 0.1% aqueous Safranin O (Sigma Aldrich) 
for 5 min. The slides were rinsed thoroughly in deionised 
water and dehydrated with 100% ethanol and Histoclear 
before being mounted using a DePEX mounting medium 
(Leica Biosystem) and visualised using the Nikon Digital 
Sight–DSFi1 camera and Nikon NIS-Elements D software 
(Nikon Metrology, UK).
RNA extraction and reverse transcription
Total RNA was extracted from cultured cells using a 
PureLink RNA Mini kit (Thermo Fisher), according to 
the manufacturer’s instructions. Briefly, cells from a 
single flask (T25 or T-75) were collected and disrupted 
with lysis buffer and 1% Gibco 2-Mercaptoethanol 
(Thermo Fisher). The lysate was then transferred to a 
1.5 mL RNase-free tube and passed through an 18-gauge 
needle multiple times for homogenisation. The samples 
were then transferred to a nucleic acid-binding spin 
cartridge with a collection tube provided by the kit 
for subsequent processes of binding, washing and 
elution accordingly. RNA purity was assessed using a 
NanoDrop ND-1000 spectrophotometer. Samples with 
an OD260/280 ratio of less than 1.8 or more than 2.2 
were rejected. RNA sample integrity was checked with 
1% agarose gel electrophoresis for discrete 18s and 28s 
ribosomal RNA gel bands. The extracted RNA was then 
subjected to DNase treatment with a Precision DNase kit 
(Primerdesign, Southampton, UK) to remove genomic 
DNA contaminations, according to manufacturer’s 
recommendations. Purified RNA was stored at −20°C 
and converted to cDNA within 1  month. 1 µg of RNA 
was reverse transcribed with a Tetro cDNA Synthesis Kit 
(Bioline, London, UK), with resulting cDNA working 
concentration of 50 ng/μL. 1 µg of purified RNA was 
mixed with 1 µL of oligodT(8) and 10 mM dNTP and 
DEPC-treated water and incubated at 65°C for 10 min. 
The reaction mix was put on ice for 2 min before being 
mixed with a 5× RT buffer, RNase inhibitor and reverse 
transcriptase (200 units). The sample mixtures were 
then incubated at 45°C for 60 min and chilled on ice at 
the end of the reaction. Reverse transcription reactions 
were conducted in duplicates per sample.
Gene expression profile with q-PCR TaqMan assay
The mRNA expression of pluripotency stem cell 
markers was studied using q-PCR with QuantStudio 7 
(Life Technologies). 50 ng cDNA (1 µL) was amplified 
with TaqMan gene expression assays (1 µL) (Applied 
Biosystem) using TaqMan Mastermix (5 µL) (Applied 
Biosystem) and sterile, distilled, nuclease-free water in a 
10 µL reaction volume. The reaction conditions were as 
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follows: 95°C for 10 min, followed by 40 cycles of 95°C 
for 15 s, then 60°C for 1 min for annealing/extension. 
Gene expression was quantified by determining the 
cycle threshold (Ct), which is the number of PCR cycles 
required for the fluorescence to become significantly 
higher than the background. Gene expression was 
normalised against expression of GUSB (endogenous 
control) and calculated using 2−ΔΔCt method. GUSB was 
selected as the endogenous control as it showed stable 
expression across all samples irrespective of culture 
condition or passage numbers, compared to other 32 
candidate genes, using TaqMan array human endogenous 
controls plate (Thermo Fisher). Each run of experiments 
were performed in triplicates. A positive control (H295R 
or MC7 cell line) was included on each experiment. 
No-template controls and RNA were also included with 
each run to check for gDNA contamination. Results 
were first analysed with QuantStudio 7 software. Target 
mRNA expression relative to GUSB was calculated using 
the comparative Ct method with Microsoft Excel and 
GraphPad Prism 6. Ct values above 39 were considered 
negative for expression. Mean gene expression (2−ΔΔCt) 
was calculated between three independent experiments 
and expressed with the standard error of the mean 
(s.e.m.). The details of the TaqMan gene expression assays 
can be found on Supplementary Table 3.
Calculations of react ion efficiency and fold-change 
of gene expression
The efficiency of each TaqMan gene expression assay 
was calculated by plotting the average triplicate Ct value 
(y-axis) against the logarithm of the amount of cDNA 
(x-axis). A 10-fold, 5-fold or a 2-fold dilution series 
were used for each gene expression assay. The assay or 
primer efficiency was determined by calculating the 
gradient of the slope between the average Ct value and 
the amount of cDNA, using linear regression analysis on 
GraphPad. The slope gradient should be approximately 
−3.32, equivalents to 100% efficiency. The primer 
efficiency (E) was calculated using the following formula 
E = 10(−1/slope) − 1 × 100. The amplification curve determining 
primary efficiency is available on Supplementary Fig. 1. All 
the TaqMan gene expression assays managed to establish 
a slope gradient between −3.22 and −3.60, corresponding 
to primer amplification efficiency of 90–105%.
All q-PCR experiments were performed in duplicates 
on the same cDNA samples on biological triplicates. 
Relative gene expression was corrected using the GUSB 
housekeeping gene. The mean fold-change expression 
(2−ΔΔCt) was calculated for mRNA expression in cells 
harvested in MGPM, in relation to cells cultured in CM, 
which were used as the control.
A (i)
A (ii)
C (i)
C (ii)
B (i)
B (ii)
D (i)
D (ii)
Figure 1
Representative images of primary cell cultures seeded in CM (i; upper panel) or MGPM (ii; lower panel), on day 2 (A), day 3 (B), day 5 (C) and passage 3 
(D). (A) (i) and (ii) the primary cells seeded in CM or MGPM were predominantly comprised large adrenocortical cells with polygonal appearance and 
light-refractive core. (B) (i) and (ii) fibroblast-like colony-forming unit (white closed-head arrow) was formed in CM and MGPM respectively. (C) (i) and (ii) 
primary cells seeded in MGPM were gradually replaced by fibroblast-like cells (ii), whereas adherent cells in CM (i) were predominantly occupied by large 
polygonal adrenocortical cells with light-refractive lipid core and fragments that protruded from the cells (black closed-head arrow). (D) (i) and (ii) a 
homogenous cell population comprised fibroblast-like cells continued to thrive in MGPM after third passage (ii). On the contrary, cell population in CM 
(i) reached senescence following passage 3. (Magnification ×100.)
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Statistical analysis
Statistical analysis was performed using paired Student’s 
t test or Wilcoxon singed-rank test. Data were analysed 
using Microsoft Excel, GraphPad, version 6 and Minitab 
version 16. All the data were expressed as the mean of 
3 sample replicates (n = 3) with the standard error of the 
mean (s.e.m.). Statistical analysis was deemed significant 
when P < 0.05.
Results
Morphology of human adrenal cortex-derived 
primary cells
Adherent cells isolated from the adrenal cortex comprised 
highly heterogeneous populations in primary culture, 
predominantly large polygonal adrenocortical cells with 
light-refractive core (Fig.  1A (i) and (ii)). However, a 
relatively homogenous population of smaller, elongated 
fibroblast-like and spindle-shaped cells were derived after 
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Figure 2
Representative MSC immunophenotype profile of adrenal cortex-derived cells seeded in CM or MGPM. The panel of histograms represent MSC 
immunophenotypes of cell populations isolated from human adrenal cortex. The adrenocortical cells displayed strong signals towards CD44, CD90, 
CD105 and CD166 markers but negative for haematopoitic, lymphocytic markers (CD19 and CD45) and HLA-DR (MHC class II). x-axes display fluorescent 
signal intensity and y-axes represent cell count. (Red histogram: unstained cells; blue histogram: negative control with fluorochrome-conjugated 
secondary antibodies only; green histogram: species-specific isotype control; yellow histogram: the staining of cells with antibodies.) The colour codes 
are applicable to all histograms except graph on MHC class I and II, where blue histogram indicates negative control, yellow and green histograms 
represent MHC class I (HLA-ABC) and MHC class II (HLA-DR), respectively.
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Figure 3
DAX1, GLI1 and CYP11B2 expression among adrenal cortex-derived cell 
populations cultivated in MGPM vs CM. Cell population harvested in 
MGPM showed significantly higher GLI1 protein expression (P = 0.046; 
95% CI for mean differences 391-16274). DAX1 was expressed in cells 
cultured in MGPM but there was negligible immunostaining in those 
harvested from CM (NS). No significant difference was demonstrated in 
CYP11B2 (expression between the cell populations harvested in either 
medium. y-axis represents the signal intensity (mean with s.e.m.).
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subsequent subcultures in MGPM (Fig.  1D (ii)), which 
survived long-term culture (up to 11 passages). On the 
contrary, adherent cells harvested in CM continued to 
exhibit heterogenous populations on subculture and 
reached senescence after 3rd passage (Fig.  1D (i)). The 
colony-forming unit fibroblast-like cells (CFU-F) were seen 
in the primary culture in either medium but cells seeded 
in MGPM exhibited a higher number of CFUs (Fig. 1B (i) 
and (ii)). On average, 4 CFU-Fs per T-75 flask had formed 
by day 7 after seeding in MGPM, compared to an average 
of 1.5 CFU-Fs per T-75 flask in CM. The identification 
of CFU-F formation and the expansion of homogenous 
cell population with fibroblast-like morphology were in 
keeping with an MSC-like phenotype.
Immunophenotyping and immunofluorescent studies
Flow cytometry immunoprofiling demonstrated that 
cell populations in both MGPM and CM harboured cells 
expressing mesenchymal markers CD44, CD90, CD105 
and CD166 but lacked expression of the haematopoetic 
and lymphocytic markers: CD19, CD45 and HLA-DR 
(Fig. 2). The mean percentage of cells positive for all the 
MSC markers studied, following the first passage was 
Figure 4
It is a representative dot plot depicting the percentage of cell population (first passage in CM and 7th passage in MGPM) dual-stained with MSC (FITC 
labelled-488/530/30) and GLI markers (APC-633/660/20). Dual-staining was indicated by the Q2 region, in which >98% of the control and species-specific 
isotype controls fall outside this area. Approximately 23.8% of the cell population in MGPM co-expressed MSC marker and GLI1 following 7 passages, 
compared with 3.4% of those cultured in CM after the first passage.
CD90/DAPICD44/DAPI CD105/DAPI CD166/DAPI
FITC-conjugated mouse antihuman ab/DAPI
(without primary ab)
FITC-conjugated mouse isotype control/DAPICD45/DAPI CD19/DAPI
Figure 5
It shows immunolabelling of adrenocortical cells cultured in MGPM for MSC surface markers. Cells from both media showed positive staining for CD 44, 
CD90, CD105 and CD166 (magnification ×200) but negative staining for CD19 and CD45 markers. (Magnification ×100.)
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significantly less in those seeded in CM compared to those 
from MGPM (CM vs MGPM; mean ± s.d.: 57.7 ± 24.6% vs 
83.9 ± 14.5%; P = 0.006). The cell population harvested 
from MGPM showed significantly higher GLI1 protein 
expression, as shown by the higher mean fluorescence 
intensity (log mean 9456) compared to those seeded in 
CM (log mean 1123) (Fig. 3; P = 0.046; 95% CI for log mean 
differences 391–16,274). There was a non-significant trend 
towards a higher mean fluorescence intensity for DAX1 
among cells seeded in MGPM compared to CM. Double-
staining of adrenal cells also revealed a cell population 
harvested in MGPM that co-expressed MSC cell-surface 
markers along with GLI1 (Fig. 4).
The flow cytometry results were then verified by 
immunofluorescent studies. Cell populations from both 
culture conditions showed strong membranous staining 
towards CD44, CD90, CD105 and CD166 markers 
but negative staining for CD19 and CD45 antibodies, 
in keeping with the flow cytometry immunoprofile 
(Fig.  5). However, cells harvested from CM lost their 
positive staining towards CD 105/CD166 with only weak 
CD44/CD90 staining following the second and third 
subcultures. In contrast, cell population in MGPM showed 
persistent positive staining towards all MSC markers on 
every subsequent subcultures. Cell populations from both 
CM and MGPM also showed positive nuclear staining for 
the adrenal-specific marker SF1, and the morphogenic 
signalling GLI1 marker (Fig. 6). GLI1 was observed to 
be more stably expressed among the cell population 
from MGPM compared to those from CM. Positive GLI1 
staining was found in two of the three adrenal samples 
seeded in CM, following first passage only. On the other 
hand, weak positive nuclear staining towards DAX1 
was limited to primary cells harvested from MGPM at 
first passage only, 5  days following subculture. Double-
immunostaining revealed that MSC markers co-localised 
with SF1 and GLI1 antigens (Fig. 7).
Multilineage differentiation capacity
Cell populations harvested in both CM and MGPM were 
examined for their multilineage differentiation capacity. 
MSC-like adrenocortical cells harvested in MGPM showed 
strong osteogenic and adipogenic differentiation capacity. 
In contrast, they exhibited poor chondrogenic capacity 
with a weak and variable degree of differentiation to the 
chondrogenic lineage; only 1 of the 3 individual adrenal 
tissue culture demonstrated weak Safranin O staining, 
indicating the presence of GAGs within the pellet matrix 
(Fig. 8A and B).
GLI(MGPM)
GLI/DAPI (CM)GLI(CM)
DAX1 (MGPM)
DAX1 (CM)
DAX1/DAPI (MGPM)
DAX1/DAPI (CM)
SF1/DAPI (MGPM)SF1 (MGPM)
SF1 (CM) SF1/DAPI (CM)
GLI/DAPI (MGPM)
Figure 6
Adrenocortical cells cultured in MGPM and CM were stained for 
expression of adrenal-specific (SF1) and stem cell morphogenic signalling 
markers (GLI1, DAX1) and examined under fluorescence microscopy. 
Nuclei were stained with DAPI (blue, right hand column). Cells cultured in 
MGPM showed positive staining for SF1, GLI1 and DAX1. The cell 
population seeded in CM demonstrated strong SF1 expression but weak 
GLI with negative DAX1 staining. (Magnification ×200.)
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Osteogenic differentiation was seen in cell populations 
from both media, as demonstrated by positive Alizarin 
Red S staining indicating the presence of extracellular 
calcium deposits (Fig.  8C and D). However, osteogenic 
induction was significantly weaker in cell populations 
harvested from CM and the same cell population failed 
to survive the induction medium for adipogenesis and 
chondrogenesis. Morphologic changes consistent with 
adipogenesis were observed as early as day-14, as shown 
by the transformation of spindle-shape fibroblast-like 
MSC cells to lipid-laden adipocyte-like cells (Fig. 8E). The 
presence of lipid vacuoles was confirmed with positive Oil 
Red O staining, consistent with adipogenesis (Fig. 8F).
Transcriptional profile with RT-q-PCR
Cell populations from both CM and MGPM were analysed 
by RT-q-PCR for the endogenous expression of pluripotent 
markers (NANOG, SOX2 and OCT4) (Fig.  9). Gene 
expression of pluripotency markers was higher in cell 
population harvested from MGPM. OCT4 expression was 
significantly higher in cells harvested in MGPM (P = 0.024, 
95% CI for mean fold-change difference: 1.07–8.71).
Discussion
This study demonstrates that the human adrenal 
cortex harbours a mesenchymal stromal/stem cell-like 
population, which exhibits the phenotypic signature of 
both MSCs and adrenocortical cells. This cell population 
maintained their proliferative capacity in the MSC growth 
promotion medium (MGPM) under hypoxic conditions 
and expressed pluripotency markers. These features suggest 
their potential role as the previously uncharacterised 
multipotent human adrenocortical progenitor cells. They 
have a high proliferative capacity and differentiated well 
along osteogenic and adipogenic lineages, but showed 
only limited chondrogenic differentiation. Distinct 
features have been observed among MSCs isolated from 
Figure 7
Double-immunostaining of adrenal cortex-derived cells with MSC and SF1/GLI markers. SF1 co-localised with MSC markers in cell populations seeded in 
either MGPM or CM, as indicated by the membranous staining of CD44/CD90 markers and positive nuclear staining for SF1 markers. Cell population 
cultured in MGPM also co-expressed MSC and GLI1 marker.
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different organs, with respect to their immunophenotype 
and secreted cytokine profile (25, 26). Hence, the limited 
chondrogenic differentiation could be due to the lack of 
innate chondrogenic potential or related to the in vitro 
cell expansion techniques.
It has been postulated that ACSCs potentially 
originate from capsular or subcapsular undifferentiated 
cells expressing GLI and SF1, whereas DAX1 is the 
transcription factor for maintaining the ‘stemness’ of 
adrenal stem/progenitor cells, by turning off the cellular 
differentiation capacity in the absence of ACTH (27). In 
this study, primary cells harvested in MGPM, but not in 
CM, strongly expressed GLI with weak DAX1 expression, 
indicating that ‘stemness’ was enhanced among the 
cell population in MGPM. This appears consistent with 
their higher proliferative capacity and potential for 
long-term culture. GLI1 is a transcription factor in the 
sonic hedgehog pathway, an essential signalling pathway 
in rodent ACSC (28). The MSC-like cells derived from 
adrenal cortex also co-expressed GLI and SF1 markers, 
enhancing the evidence that they were predominantly 
adrenal progenitor cells. However, this study had a few 
limitations. Firstly, primary adrenal cortex-derived cells 
comprised highly heterogeneous cell populations in 
line with the zonal differentiation of the gland and 
hence it is unlikely that there will be a single defining 
molecular characteristic of these derived cell populations. 
Nevertheless, following isolation, hypoxic culture and 
several passages in mesenchymal growth media, our work 
is consistent with a homogenous population of MSC-like 
cells existing within human adult adrenal cortex. These 
MSC-like adrenocortical cells could either represent a static 
population of adrenocortical progenitors or non-ACSCs 
that co-exist in the stem cell niche with MSC properties 
that have migrated from other tissues. Furthermore, as this 
is the first study to isolate MSC-like cells from the human 
adrenal cortex, there are no established protocols for this. 
Therefore, different isolation and culture techniques, such 
as the use of a digestive enzyme like the recombinant 
fungal trypsin-like protease used in this study, might affect 
MSC function or differentiation capacity by nonspecific 
degradation.
Figure 8
It demonstrates the multilineage differentiation capacity of adrenal 
cortex-derived cells. Adrenal cells cultured in MGPM were processed into 
cell pellets and induced with chondrogenic differentiation medium for 
21 days. One of three cell pellets (from 3 individual patients) 
demonstrated weak staining with Safranin O solution, signifying the 
presence of GAG (A) but two of the remaining 2 showed negative 
staining (B). Only cells seeded in MGPM survived adipogenic 
differentiation medium and differentiated into adipogenic cells in 
abundance, as indicated by cellular accumulation of lipid-rich vacuoles 
(C), which stained with Oil Red O (D). Cell population seeded in either CM 
or MGPM (E) or CM (F) differentiated into osteogenic lineage at day-21 
with enhancement of alkaline phosphatase activity as shown by the 
positive staining for Alizarin S.
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Figure 9
Adrenal cortex-derived cells cultured in CM and MGPM respectively were 
analysed by q-PCR for the endogenous expression of pluripotency 
markers (NANOG, OCT4 and SOX2) and steroidogenic factor 1 marker. 
Error bars represent standard error of means for cell population from 3 
individual patient-derived cultures. Fold changes of gene expression were 
calculated with the 2−ΔΔCT method, using GUSB as the house keeping 
gene. Results were shown as mean ± s.e.m. from triplicates (n = 3), using 
paired T test. Differences in gene expression OCT4 was statistically 
significant in cell population harvested from MGPM (**P-value <0.05) 
relative to the cell population cultured in CM.
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The identification of a MSC-like population in the 
adrenal cortex has contributed towards our understanding 
of adrenal plasticity. Although these adrenal cortex-derived 
MSC-like cells are yet to be proven as ACSC, they have been 
found to exhibit features consistent with progenitor cells. 
Similar to non-bone marrow-derived MSC isolated from 
other tissues, the exact anatomical location of these MSC-
like cells in intact human adrenal has not been defined. 
Many studies suggest that this group of cells resides on 
the luminal surface of endothelial cells in the perivascular 
niche, namely pericytes or adventitial cells (29, 30). They 
have also been shown to home in on injured or inflamed 
tissues, with anti-inflammatory properties. They promote 
tissue repair through the production of trophic factors, 
which reduce inflammation and facilitate functional 
recovery of the damaged cells (31, 32, 33). Promising 
results have been demonstrated in experimental murine 
models of acute tissue injury and autoimmunity, such as 
autoimmune encephalomyelitis, glomerulonephritis and 
acute fulminant liver failure (34, 35, 36). Interestingly, MSCs 
seem to demonstrate plasticity and to have the capacity to 
adapt functionally according to their environment, as MSC 
therapy has been shown to work in active autoimmune 
encephalitis but not during remission (37, 38). A few phase 
I clinical trials have also demonstrated clinical safety and 
the feasibility of MSC therapy in inflammatory bowel 
disease (39), liver cirrhosis (40) and myocardial infarction 
(41). In view of these encouraging preliminary results, the 
discovery of MSC-like cells in the human adrenal cortex 
should prompt further investigation with respect to their in 
vivo identity and biological function, to form a potentially 
therapeutic tool for adrenal diseases.
MSC therapy certainly appears to have attractive 
therapeutic potential in autoimmune diseases. 
Experimental treatments of type 1 diabetes using MSC 
therapy in murine models have already shown some 
promising results. These studies demonstrated an increase 
in the number of pancreatic insulin-producing beta-cells 
with suppression of auto-reactive T lymphocytes and 
inflammatory dendritic cells, leading to long-term reversal 
of hyperglycaemia (32, 42, 43). With this in mind, an 
understanding of the cell biology of adrenal-derived MSCs 
will be essential to the regenerative medicine approach in 
AAD as well as other autoimmune endocrine diseases (i.e. 
Graves’ orbitopathy). Furthermore, these cells are strongly 
implicated in adrenocortical cancer and improved 
knowledge of their characteristics has the potential to 
inform future cancer therapy.
The anatomical niche of adrenal-MSCs at the tissue 
level, as well as the genomic and proteomic properties of 
this cell population, also warrants detailed investigation, 
potentially by q-PCR and proteomic studies with single-
cell analysis. A comprehensive high-throughput screening 
of the actions of various morphogenic and transcription 
factors during differentiation of MSC to steroidogenic 
cells will also help identify the agents or factors essential 
for adrenal self-renewal and long-term steroidogenesis. 
Finally, developing a method for differentiating MSCs into 
steroidogenic cells, in which the bone marrow or adipose 
tissues are a rich source for MSCs, could potentially lead 
to curative cell therapy for AAD.
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